BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Heart
,
Hematopoietic cell
,
Aspirin
,
rs7903146
,
FXYD4
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
METAP2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Parotid gland
Hematopoietic stem cell of bone marrow
Jejunum
Ileum mucosa
Colon mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Inflammatory disease of liver
Chronic fatigue syndrome
Disorder of intraocular pressure
Bleeding
Liver cancer
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
halofantrine
Trapidil
imidazolidinyl urea
Nafronyl
rilmenidine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-1-3p
PCSK9
ZBTB4
FANCG
SLC7A5
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Methionine aminopeptidase‑2 is a pivotal regulator of vasculogenic mimicry.
MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle ce…
The methionine aminopeptidase 2 inhibitor, TNP-470, enhances the antidiabetic properties of sitaglip…
MetAP2 inhibition increases energy expenditure through direct action on brown adipocytes.
MetAP2 inhibitor treatment of high-fat and -fructose-fed dogs: impact on the response to oral glucos…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin’s Lymphoma and Solid Tumors
A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
Evexomostat Plus Alpelisib and Fulvestrant in Postmenopausal Women at Risk for Hyperglycemia With Br…
M8891 First in Human in Solid Tumors
A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ